‘We’ll look back and say that this was a bargain.’ Takeda reveals first data from its $4 billion autoimmune disease pill. – The Boston Globe

by

  1. ‘We’ll look back and say that this was a bargain.’ Takeda reveals first data from its $4 billion autoimmune disease pill. The Boston Globe
  2. Takeda’s $4 Billion Psoriasis Pill Helped Clear Skin in Mid-Stage Study Bloomberg
  3. Takeda Announces Positive Results in Phase 2b Study of Investigational TAK-279, an Oral, Once-Daily TYK2 Inhibitor, in People with Moderate-to-Severe Plaque Psoriasis Business Wire
  4. Takeda reveals first data from its $4 billion autoimmune disease pill STAT
  5. Takeda raised to Buy at BofA on growth prospects and debt repayment (NYSE:TAK) Seeking Alpha
  6. View Full Coverage on Google News

Read original article here

Leave a Comment